SDP Data Analytics is the computational backbone of our platform extending untargeted mass spectrometry screening beyond conventional affinity-based methods. By combining high-reproducibility mass spectrometry acquisition with our advanced AI-driven analytics, SDP enables unbiased exploration of chemical space and rapid prioritization of biologically relevant signals. Designed for compatibility, scalability, and confidentiality, the platform delivers a secure and efficient path from raw spectra to ranked candidates ready for validation and optimization.
For projects requiring strict confidentiality, we offer blind-screening services where raw mass spectrometry data are processed inside encrypted, isolated containers, and all input files are permanently deleted following delivery of results. For collaborations or to access our library screening services, please contact us at info@LinkerSciences.com.
Key Features:
Ensures No Peak Left Behind Strategy
Treats every m/z signal as a potential drug-like candidate, capturing low-abundance but biologically relevant compounds.
Supports Instrument-Agnostic Compatibility
Operates seamlessly across LC–MS and GC–MS platforms, processing data from EI, ESI, and APCI ionization sources as well as DDA, DIA, and CCS acquisition modes.
Delivers Bias-Free Screening
Extends detection beyond known scaffolds, enabling discovery of novel metabolites and molecular classes.
Prioritizes with AI-Powered Analytics
Applies algorithms integrating spectral patterns, structural predictions, and pharmacophore similarity to rank hits for progression.
Provides Secure & Confidential Processing
Executes all analytics in a cloud environment with optional blind-screening services, encrypted containers, and permanent data deletion.